Homepage

Sandoz HACk - Healthcare Access Challenge

Three winners of 2019 Sandoz Healthcare Access Challenge (HACk) are announced at SXSW
Read More
our-mission-and-purpose

Our Mission and Purpose

We are a global leader in generic and biosimilar pharmaceuticals, committed to driving access to medicine
Read More

Explore Novartis

About Us
Who We Are
Our Work
What We Do
About Us
Corporate Responsibility
Careers
Job Search

Recent Updates

Featured / Jul 02

Why opening the door to generics on day one is no brainer

There is no denying that having more choice increases our flexibility, autonomy, freedom and gives more control back ...

Learn More
View All
Media Release / Aug 09

Sandoz will appeal District Court of New Jersey ruling in biosimilar Erelzi® (etanercept-szzs) US patent case

Read More
Media Release / Jul 22

Sandoz announces first patient enrolled in clinical study for proposed biosimilar denosumab in osteoporosis

Read More
Media Release / Jul 18

Novartis delivers strong sales, double digit core operating income growth and launches Zolgensma and Piqray in second quarter; sales and profit guidance increased

Read More
Media Release / Jul 09

Sandoz extends SYMJEPI™ (epinephrine) Injection launch to US pharmacies to help improve patient access to life-saving medicine

Read More
View All
Due to complex manufacturing processes and use of living cells, all biologics-reference medicines & #biosimilars-sh… https://t.co/v8JEoeATq9 1 day 3 hours ago

Our Work

At Sandoz, we discover new ways to improve and extend people’s lives. We pioneer novel approaches to help people around the world access high-quality medicine.

Learn More